Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

SELL
$9.4 - $14.04 $19,721 - $29,455
-2,098 Reduced 5.1%
39,056 $368,000
Q2 2023

Jul 24, 2023

SELL
$12.96 - $20.93 $19,621 - $31,688
-1,514 Reduced 3.55%
41,154 $574,000
Q1 2023

Apr 17, 2023

SELL
$13.48 - $18.79 $8,357 - $11,649
-620 Reduced 1.43%
42,668 $800,000
Q4 2022

Jan 11, 2023

BUY
$12.61 - $18.74 $5,737 - $8,526
455 Added 1.06%
43,288 $596,000
Q3 2022

Oct 20, 2022

SELL
$15.33 - $20.36 $59,817 - $79,444
-3,902 Reduced 8.35%
42,833 $818,000
Q2 2022

Jul 08, 2022

BUY
$11.63 - $21.55 $45,357 - $84,045
3,900 Added 9.1%
46,735 $713,000
Q1 2022

Apr 14, 2022

SELL
$16.63 - $27.73 $9,894 - $16,499
-595 Reduced 1.37%
42,835 $872,000
Q4 2021

Jan 12, 2022

BUY
$20.7 - $34.18 $899,001 - $1.48 Million
43,430 New
43,430 $1.27 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $770M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.